In this study, for the first time, we identified two types of mutations in the PPP2R2A gene in leukemic blasts from three AML patients leading to loss of B55α protein expression and a significant increase in AKT Thr-308 phosphorylation. The gene discussed is AKT1; the disease is acute myeloid leukemia.